Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Authoring Organizations

Publication Month/Year

June 4, 2021

Document Type


Country of Publication


Target Patient Population

Neurologists and pediatric neurologists in secondary and tertiary care settings

Target Provider Population

Patients of any age, presenting with clinical features suggestive of CIDP

Inclusion Criteria

Male, Female, Adolescent, Adult, Child, Infant, Older adult

Health Care Settings


Intended Users

Nurse, nurse practitioner, physician, physician assistant


Diagnosis, Assessment and screening, Treatment, Management

Diseases/Conditions (MeSH)

D020277 - Polyradiculoneuropathy, Chronic Inflammatory Demyelinating


chronic inflammatory demyelinating polyneuropathy (CIDP), chronic inflammatory demyelinating polyradiculoneuropathy, CIDP

Source Citation

Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, Attarian S, Blomkwist-Markens PH, Cornblath DR, Eftimov F, Goedee HS, Harbo T, Kuwabara S, Lewis RA, Lunn MP, Nobile-Orazio E, Querol L, Rajabally YA, Sommer C, Topaloglu HA. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. J Peripher Nerv Syst. 2021 Sep;26(3):242-268. doi: 10.1111/jns.12455. Epub 2021 Jul 30. Erratum in: J Peripher Nerv Syst. 2022 Jan 10;: Erratum in: Eur J Neurol. 2022 Jan 14;: PMID: 34085743.

Supplemental Methodology Resources

Data Supplement


Number of Source Documents
Literature Search Start Date
June 1, 2018
Literature Search End Date
July 1, 2019